ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,347.12
0.14%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) Noticias

SPRC

SciSparc (SPRC)

SciSparc Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SPRC
FechaHoraFuenteTítuloSímboloCompañía
31/12/202415:16Edgar (US Regulatory)Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]NASDAQ:SPRCSciSparc Ltd
31/12/202415:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
31/12/202408:24GlobeNewswire Inc.SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum DisorderNASDAQ:SPRCSciSparc Ltd
26/12/202415:06Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SPRCSciSparc Ltd
26/12/202405:46GlobeNewswire Inc.SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct ImportationNASDAQ:SPRCSciSparc Ltd
16/12/202406:40GlobeNewswire Inc.SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded CompanyNASDAQ:SPRCSciSparc Ltd
30/09/202408:25GlobeNewswire Inc.SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
26/09/202408:05GlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareXNASDAQ:SPRCSciSparc Ltd
23/09/202407:17GlobeNewswire Inc.SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
18/09/202415:09GlobeNewswire Inc.SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
16/09/202415:06GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination TherapyNASDAQ:SPRCSciSparc Ltd
11/09/202406:40GlobeNewswire Inc.SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle ManufacturerNASDAQ:SPRCSciSparc Ltd
06/09/202406:55GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:SPRCSciSparc Ltd
06/09/202406:55GlobeNewswire Inc.Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:SPRCSciSparc Ltd
05/09/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SPRCSciSparc Ltd
29/08/202415:25GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based CombinationNASDAQ:SPRCSciSparc Ltd
28/08/202415:05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:SPRCSciSparc Ltd
28/08/202407:55GlobeNewswire Inc.SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 MillionNASDAQ:SPRCSciSparc Ltd
23/08/202415:09GlobeNewswire Inc.SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette SyndromeNASDAQ:SPRCSciSparc Ltd
22/08/202407:12GlobeNewswire Inc.SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory BoardNASDAQ:SPRCSciSparc Ltd
19/08/202415:11GlobeNewswire Inc.SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 TreatmentNASDAQ:SPRCSciSparc Ltd
16/08/202415:30GlobeNewswire Inc.SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 millionNASDAQ:SPRCSciSparc Ltd
14/08/202415:53GlobeNewswire Inc.SciSparc Updates Regarding the Status of the AutoMax MergerNASDAQ:SPRCSciSparc Ltd
06/08/202407:57GlobeNewswire Inc.SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss DrugNASDAQ:SPRCSciSparc Ltd
17/07/202406:07GlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 millionNASDAQ:SPRCSciSparc Ltd
16/07/202410:55GlobeNewswire Inc.SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:SPRCSciSparc Ltd
16/07/202405:03GlobeNewswire Inc.SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight LossNASDAQ:SPRCSciSparc Ltd
08/07/202407:30GlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded CompanyNASDAQ:SPRCSciSparc Ltd
17/06/202415:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SPRCSciSparc Ltd
31/05/202406:17GlobeNewswire Inc.SciSparc Secures Strategic Advantage with Grant of European PatentNASDAQ:SPRCSciSparc Ltd
 Showing the most relevant articles for your search:NASDAQ:SPRC

Su Consulta Reciente

TG
SE5B
Schaeffler
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados